In part 3 of this slideshow series, take a look back at the novel drugs and therapeutics approved by the FDA in 2023,1 including treatments for postpartum depression, relapsed or refractory multiple myeloma, and major depressive disorder.
Q&A: How an Army Veteran Began His Journey to Overcoming PTSD
July 11th 2024“They may not understand. But I tell people, ‘I don't want you to understand me.’ I don't understand me. But if you can relate to me, then that furthers our conversation—the relatedness,” said Farron Dozier on his experience with PTSD.